Filing Details

Accession Number:
0001144204-14-069235
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-17 16:35:25
Reporting Period:
2014-11-13
Filing Date:
2014-11-17
Accepted Time:
2014-11-17 16:35:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
905011 M Michael Goldberg C/O Montaur Capital Partners
152 W. 57Th Street, 4Th Floor
New York NY US 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-13 71,641 $1.06 261,352 No 4 P Direct
Common Stock Acquisiton 2014-11-14 28,359 $1.12 289,711 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.0499 and $1.0727. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $1.09 and $1.13. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.